QR Group Explains the Changes in RDC 954/2024 and Its Impact on Drug Registration

ANVISA RDC 954/2024 update for drug registration.

Understand How the Changes in RDC 954/2024 Impact Drug Registration and How QR Group Assists International Manufacturers With the entry into force of RDC 954/2024, the drug registration process undergoes significant changes. The rule revises and simplifies the regulatory procedure, promoting greater speed in the registration, post-registration and renewal processes. QR Group, a specialist in […]